Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Cash (2017 - 2025)

Catheter Precision (VTAK) has disclosed Change in Cash for 9 consecutive years, with $237000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash fell 81.07% to $237000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$193000.0, a 95.52% increase, with the full-year FY2024 number at -$692000.0, up 94.37% from a year prior.
  • Change in Cash was $237000.0 for Q3 2025 at Catheter Precision, down from $388000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $4.3 million in Q2 2021 to a low of -$8.0 million in Q1 2021.
  • A 5-year average of -$1.2 million and a median of -$1.5 million in 2024 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: crashed 306.38% in 2021, then skyrocketed 538.64% in 2022.
  • Catheter Precision's Change in Cash stood at -$5.6 million in 2021, then soared by 139.53% to $2.2 million in 2022, then crashed by 191.46% to -$2.0 million in 2023, then soared by 179.69% to $1.6 million in 2024, then crashed by 85.23% to $237000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Change in Cash are $237000.0 (Q3 2025), $388000.0 (Q2 2025), and -$2.4 million (Q1 2025).